Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
04/2007
04/18/2007CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents
04/18/2007CN1950344A Pharmaceutical compositions
04/18/2007CN1950081A Arylalkylamino-substituted quinazoline analogues
04/18/2007CN1310892C Dithiocarbamate derivatives and their use as antibacterial agents
04/17/2007US7205405 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one
04/17/2007US7205310 inflammatory conditions such as multiple sclerosis
04/17/2007US7205309 Obesity therapy; administering orlistat
04/17/2007US7205307 Pyrimidines as novel openers of potassium ion channels
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/17/2007US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity
04/17/2007US7205260 Uracil derivative and protoporphyrinogen oxidase-inhibiting N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoaxazine-6-yl)cyclohex-1-ene-1,2-dicarboxamide and N-[2,4-dichloro-5-[4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]methansulfonamide; orchards, soybeans
04/17/2007US7205001 Anticancer agents; using potassium arsenite therapy and radiation
04/17/2007CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids
04/17/2007CA2141589C Antiretroviral enantiomeric nucleotide analogs
04/17/2007CA2106882C Azaquinoxalines, processes for their preparation and their use
04/12/2007WO2007041666A1 Preparation of rosuvastatin
04/12/2007WO2007041634A1 Pyrimidine amide compounds as pgds inhibitors
04/12/2007WO2007041366A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007WO2007040940A1 Diastereomeric purification of rosuvastatin
04/12/2007WO2007040231A1 Quinazoline derivative and pharmaceutical
04/12/2007WO2007039499A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives
04/12/2007WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
04/12/2007WO2007039112A1 Novel phloroglucinol derivatives having selectin ligand activity
04/12/2007WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
04/12/2007WO2006104889A3 Novel compounds
04/12/2007WO2006078598A3 Mitotic kinesin inhibitors
04/12/2007WO2006063792A3 Crystal structure of enzyme and uses thereof
04/12/2007WO2006021458A3 Pyrimidine derivatives
04/12/2007WO2006020830A3 Bisaryl-sulfonamides
04/12/2007US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
04/12/2007US20070082921 Quinazoline derivatives as antitumor agents
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007CA2851103A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007CA2625290A1 Preparation of rosuvastatin
04/12/2007CA2624801A1 Diastereomeric purification of rosuvastatin
04/12/2007CA2624524A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007CA2624450A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007CA2624141A1 Quinazoline derivative and pharmaceutical
04/12/2007CA2624020A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives
04/12/2007CA2623686A1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007CA2622467A1 Novel phloroglucinol derivatives having selectin ligand activity
04/12/2007CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
04/11/2007EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds
04/11/2007EP1771452A2 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
04/11/2007EP1771447A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases
04/11/2007EP1771427A1 Prostaglandin analogs
04/11/2007EP1771422A1 Quinazolinone derivatives as parp inhibitors
04/11/2007EP1771421A1 N-hydroxyamide derivatives and use thereof
04/11/2007EP1771418A2 Large conductance calcium-activated k channel opener
04/11/2007EP1771176A2 Methods and compositions
04/11/2007EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents
04/11/2007CN1946703A Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
04/11/2007CN1946701A Tri-substituted ureas as cytokine inhibitors
04/11/2007CN1946700A Tri-substituted ureas as cytokine inhibitors
04/11/2007CN1309719C Derivative of phenylamide pyrimidine and application thereof
04/11/2007CN1309710C Pyrimidine derivitive
04/10/2007US7202368 Process for the preparation of 4-(benzimidazolymethylamino) benzamidines
04/10/2007US7202360 Reacting 2,4-difluorophenyl (4-piperidinyl) methanone oxime hydrochloride and 3-(2-haloethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali solution: high yeild when alkali hydroxide concentration is in the range of 20 to 40%
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202251 Bicyclic anilide spirohydantoin CGRP receptor antagonists
04/10/2007US7202244 Chk-1 inhibitors
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/10/2007CA2104148C Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of n,n'-substituted ureas
04/05/2007WO2007036713A2 Chemical process
04/05/2007WO2007036477A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides
04/05/2007WO2007000392A3 Chloro-substituted guanidines
04/05/2007US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/05/2007US20070078106 A 5-substituted uracil or 5,6-dihydro-5-substituted uracil, potentiate 5-fluorouracil; 5-substituent is selected from bromo, ido, cyano, halo-substituted C1-4 alkyl, C2-6 alkenyl, 1-halo-C2-6 alkenyl andhalo-substituted C2-6 alkynyl; antitumor agents; anticarcinogenic agents
04/05/2007US20070077196 Radiolabeled thymidine solid-phase extraction purification method
04/05/2007CA2745829A1 Chemical process
04/05/2007CA2623063A1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
04/05/2007CA2621967A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides
04/04/2007EP1768978A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
04/04/2007EP1768964A1 Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer
04/04/2007EP1768963A2 Cancer treatment method
04/04/2007EP1768951A2 Non-natural amino acids
04/04/2007EP1219609B1 Aromatic nitrogenous six-membered ring compounds
04/04/2007CN1942188A Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
04/04/2007CN1939910A Amino-metadiazine compound and its salt, its preparation and pharmaceutical use
04/04/2007CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/04/2007CN1308297C Phenyl sulfamate derivatives
04/03/2007US7199392 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds
04/03/2007US7199239 Chemical compounds
04/03/2007US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists
04/03/2007US7199119 Antiinflammation agents
04/03/2007US7198958 Method for increasing hydrophilicity of fluorescent label compounds
04/03/2007CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/03/2007CA2309350C Purine derivatives and medicaments comprising the same as active ingredient
04/03/2007CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
04/03/2007CA2288140C Farnesyltransferase inhibiting quinazolinones
03/2007
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007US20070073060 Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease
03/29/2007US20070072942 Statin derivatives
03/29/2007US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide
03/29/2007US20070072876 Novel pyrimidine carboxamides